A019170 Stock Overview
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Shinpoong Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩14,240.00 |
| 52 Week High | ₩22,800.00 |
| 52 Week Low | ₩9,560.00 |
| Beta | 0.93 |
| 1 Month Change | -8.19% |
| 3 Month Change | 23.83% |
| 1 Year Change | -21.63% |
| 3 Year Change | -76.35% |
| 5 Year Change | 79.35% |
| Change since IPO | 649.31% |
Recent News & Updates
Recent updates
Shinpoong Pharmaceutical Co.,Ltd (KRX:019170) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Apr 24
Do Shin Poong Pharm.Co.Ltd's (KRX:019170) Earnings Warrant Your Attention?
Mar 07Declining Stock and Decent Financials: Is The Market Wrong About Shin Poong Pharm.Co.,Ltd. (KRX:019170)?
Feb 01
We Wouldn't Rely On Shin Poong Pharm.Co.Ltd's (KRX:019170) Statutory Earnings As A Guide
Jan 05Is Shin Poong Pharm.Co.Ltd (KRX:019170) Using Too Much Debt?
Dec 10Shareholder Returns
| A019170 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 5.6% | 2.1% | 2.2% |
| 1Y | -21.6% | 8.6% | 6.7% |
Return vs Industry: A019170 underperformed the KR Pharmaceuticals industry which returned 8.6% over the past year.
Return vs Market: A019170 underperformed the KR Market which returned 6.7% over the past year.
Price Volatility
| A019170 volatility | |
|---|---|
| A019170 Average Weekly Movement | 11.2% |
| Pharmaceuticals Industry Average Movement | 4.5% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A019170's share price has been volatile over the past 3 months.
Volatility Over Time: A019170's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | 828 | n/a | shinpoong.co.kr |
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products.
Shinpoong Pharmaceutical Co.,Ltd Fundamentals Summary
| A019170 fundamental statistics | |
|---|---|
| Market cap | ₩746.18b |
| Earnings (TTM) | -₩57.33b |
| Revenue (TTM) | ₩200.23b |
3.6x
P/S Ratio-12.7x
P/E RatioIs A019170 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A019170 income statement (TTM) | |
|---|---|
| Revenue | ₩200.23b |
| Cost of Revenue | ₩119.95b |
| Gross Profit | ₩80.28b |
| Other Expenses | ₩137.60b |
| Earnings | -₩57.33b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.12k |
| Gross Margin | 40.09% |
| Net Profit Margin | -28.63% |
| Debt/Equity Ratio | 16.6% |
How did A019170 perform over the long term?
See historical performance and comparison